Cardiovascular comorbidities antedating the diagnosis of rheumatoid arthritis

被引:43
|
作者
Kerola, Anne M. [1 ,2 ,3 ]
Kerola, Tuomas [3 ]
Kauppi, Markku J. [2 ,4 ]
Kautiainen, Hannu [5 ]
Virta, Lauri J. [6 ]
Puolakka, Kari [7 ]
Nieminen, Tuomo V. M. [3 ,4 ,8 ]
机构
[1] Univ Helsinki, Sch Med, FI-00029 Helsinki, Finland
[2] Paijat Hame Cent Hosp, Div Rheumatol, Dept Internal Med, Lahti, Finland
[3] Paijat Hame Cent Hosp, Div Cardiol, Dept Internal Med, Lahti, Finland
[4] Univ Tampere, Sch Med, FIN-33101 Tampere, Finland
[5] Kuopio Univ Hosp, Unit Primary Hlth Care, SF-70210 Kuopio, Finland
[6] Social Insurance Inst, Res Dept, Turku, Finland
[7] South Karelia Cent Hosp, Dept Med, Lappeenranta, Finland
[8] Univ Helsinki, Cent Hosp, Div Cardiol, FI-00029 Helsinki, Finland
关键词
Rheumatoid Arthritis; Cardiovascular Disease; Rheumatoid Factor; Epidemiology; POPULATION-BASED COHORT; CORONARY-HEART-DISEASE; RISK-FACTORS; MYOCARDIAL-INFARCTION; PROGNOSTIC-FACTORS; ONSET; MORTALITY; AGE; POLYMORPHISM; FINLAND;
D O I
10.1136/annrheumdis-2012-202398
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives To assess the prevalence of coronary heart disease (CHD) and chronic hypertension among patients with rheumatoid arthritis (RA) at the time of diagnosis, in comparison with age-specific and sex-specific non-RA subjects. Furthermore, the impacts of age at the onset of RA, as well as gender and the presence of rheumatoid factor (RF) on the risk of these comorbidities, were evaluated. Methods A cohort of 7209 RA patients diagnosed between January 2004 and December 2007 was identified, based on a Finnish nationwide register on special reimbursements for medication costs. The presence of CHD and chronic hypertension antedating the diagnosis of RA was identified from the same register. The prevalence of the cardiovascular comorbidities was compared with the general Finnish population, and a standardised rate ratio (SRR) for both these cardiovascular diseases was calculated. Results The risk of having CHD at RA diagnosis was slightly elevated, the SRR being 1.10 (95% CI 1.01 to 1.20). Younger age at the onset of RA seemed to be related with higher SRR for CHD. In a subset analysis, an increased prevalence of hypertension (SRR 1.19, 95% CI 1.10 to 1.30) and CHD (SRR 1.15, 95% CI 1.00 to 1.32) was apparent only among the RF negative RA cases. Conclusions The SRR for CHD is augmented in RA patients already at disease onset, and more pronouncedly in early onset RA. The findings highlight the importance of early prevention of atherosclerosis, regardless of RF status.
引用
收藏
页码:1826 / 1829
页数:4
相关论文
共 50 条
  • [1] Cardiovascular and Metabolic Comorbidities in Rheumatoid Arthritis
    Romano, Silvio
    Salustri, Elisa
    Ruscitti, Piero
    Carubbi, Francesco
    Penco, Maria
    Giacomelli, Roberto
    CURRENT RHEUMATOLOGY REPORTS, 2018, 20 (12)
  • [2] Cardiovascular comorbidities in rheumatoid arthritis
    Krueger, K.
    Nuesslein, H.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2019, 78 (03): : 221 - 227
  • [3] Practical Management of Cardiovascular Comorbidities in Rheumatoid Arthritis
    Gualtierotti, Roberta
    Ughi, Nicola
    Marfia, Giovanni
    Ingegnoli, Francesca
    RHEUMATOLOGY AND THERAPY, 2017, 4 (02) : 293 - 308
  • [4] Prevalence of Cardiovascular Comorbidities in Patients with Rheumatoid Arthritis
    Rus, Marius
    Ardelean, Adriana Ioana
    Pusta, Claudia Judea
    Crisan, Simina
    Marian, Paula
    Pobirci, Liliana Oana
    Huplea, Veronica
    Osiceanu, Alina Stanca
    Osiceanu, Gheorghe Adrian
    Andronie-Cioara, Felicia Liana
    Guler, Madalina Ioana
    MEDICINA-LITHUANIA, 2024, 60 (01):
  • [5] Practical Management of Cardiovascular Comorbidities in Rheumatoid Arthritis
    Roberta Gualtierotti
    Nicola Ughi
    Giovanni Marfia
    Francesca Ingegnoli
    Rheumatology and Therapy, 2017, 4 : 293 - 308
  • [6] Cardiovascular and Metabolic Comorbidities in Rheumatoid Arthritis
    Silvio Romano
    Elisa Salustri
    Piero Ruscitti
    Francesco Carubbi
    Maria Penco
    Roberto Giacomelli
    Current Rheumatology Reports, 2018, 20
  • [7] Rheumatoid Arthritis: Cardiovascular Manifestations, Pathogenesis, and Therapy
    Mellana, William M.
    Aronow, Wilbert S.
    Palaniswamy, Chandrasekar
    Khera, Sahil
    CURRENT PHARMACEUTICAL DESIGN, 2012, 18 (11) : 1450 - 1456
  • [8] Cardiovascular risk in rheumatoid arthritis
    Nurmohamed, Michael T.
    AUTOIMMUNITY REVIEWS, 2009, 8 (08) : 663 - 667
  • [9] Comorbidities in rheumatoid arthritis
    Dougados, Maxime
    CURRENT OPINION IN RHEUMATOLOGY, 2016, 28 (03) : 282 - 288
  • [10] Impact of disease activity and treatment of comorbidities on the risk of myocardial infarction in rheumatoid arthritis
    Meissner, Yvette
    Zink, Angela
    Kekow, Joern
    Rockwitz, Karin
    Liebhaber, Anke
    Zinke, Silke
    Gerhold, Kerstin
    Richter, Adrian
    Listing, Joachim
    Strangfeld, Anja
    ARTHRITIS RESEARCH & THERAPY, 2016, 18